Arrow Greentech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 4:56 pm

Competitors of Arrow Greentech Ltd

All Competitor Stocks of Arrow Greentech Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:40 pm

Below is a detailed analysis of the quarterly data for Arrow Greentech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 15.00 Cr..
• For Expenses, as of Jun 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 41.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 14.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 34.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Mar 2025) to 34.00%, marking an increase of 6.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 23.00%, marking a decrease of 5.00%.
• For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.22. The value appears to be declining and may need further review. It has decreased from 7.58 (Mar 2025) to 7.22, marking a decrease of 0.36.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:42 am

Growth

Last Updated: September 4, 2025, 11:35 pm

Balance Sheet

Last Updated: October 10, 2025, 1:39 pm

Below is a detailed analysis of the balance sheet data for Arrow Greentech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Mar 2024) to 173.00 Cr., marking an increase of 61.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 208.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 145.00 Cr. (Mar 2024) to 208.00 Cr., marking an increase of 63.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 46.00 Cr..
• For Other Assets, as of Mar 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 104.00 Cr. (Mar 2024) to 123.00 Cr., marking an increase of 19.00 Cr..
• For Total Assets, as of Mar 2025, the value is 208.00 Cr.. The value appears strong and on an upward trend. It has increased from 145.00 Cr. (Mar 2024) to 208.00 Cr., marking an increase of 63.00 Cr..

Notably, the Reserves (173.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Arrow Greentech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 41.83. This value is within the healthy range. It has increased from 19.56 (Mar 24) to 41.83, marking an increase of 22.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is 41.83. This value is within the healthy range. It has increased from 19.56 (Mar 24) to 41.83, marking an increase of 22.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 46.66. This value is within the healthy range. It has increased from 24.63 (Mar 24) to 46.66, marking an increase of 22.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 124.76. It has increased from 84.07 (Mar 24) to 124.76, marking an increase of 40.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 124.76. It has increased from 84.07 (Mar 24) to 124.76, marking an increase of 40.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 161.26. It has increased from 98.43 (Mar 24) to 161.26, marking an increase of 62.83.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 62.03. This value is within the healthy range. It has increased from 32.43 (Mar 24) to 62.03, marking an increase of 29.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 57.13. This value is within the healthy range. It has increased from 27.24 (Mar 24) to 57.13, marking an increase of 29.89.
• For PBT / Share (Rs.), as of Mar 25, the value is 56.99. This value is within the healthy range. It has increased from 26.94 (Mar 24) to 56.99, marking an increase of 30.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 41.76. This value is within the healthy range. It has increased from 19.44 (Mar 24) to 41.76, marking an increase of 22.32.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 41.84. This value is within the healthy range. It has increased from 19.56 (Mar 24) to 41.84, marking an increase of 22.28.
• For PBDIT Margin (%), as of Mar 25, the value is 38.46. This value is within the healthy range. It has increased from 32.94 (Mar 24) to 38.46, marking an increase of 5.52.
• For PBIT Margin (%), as of Mar 25, the value is 35.42. This value exceeds the healthy maximum of 20. It has increased from 27.67 (Mar 24) to 35.42, marking an increase of 7.75.
• For PBT Margin (%), as of Mar 25, the value is 35.34. This value is within the healthy range. It has increased from 27.37 (Mar 24) to 35.34, marking an increase of 7.97.
• For Net Profit Margin (%), as of Mar 25, the value is 25.89. This value exceeds the healthy maximum of 10. It has increased from 19.74 (Mar 24) to 25.89, marking an increase of 6.15.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 25.94. This value exceeds the healthy maximum of 20. It has increased from 19.86 (Mar 24) to 25.94, marking an increase of 6.08.
• For Return on Networth / Equity (%), as of Mar 25, the value is 33.53. This value is within the healthy range. It has increased from 23.26 (Mar 24) to 33.53, marking an increase of 10.27.
• For Return on Capital Employeed (%), as of Mar 25, the value is 44.51. This value is within the healthy range. It has increased from 31.28 (Mar 24) to 44.51, marking an increase of 13.23.
• For Return On Assets (%), as of Mar 25, the value is 30.29. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 30.29, marking an increase of 9.99.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.38. It has increased from 1.11 (Mar 24) to 1.38, marking an increase of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 10.34. This value exceeds the healthy maximum of 3. It has increased from 5.98 (Mar 24) to 10.34, marking an increase of 4.36.
• For Quick Ratio (X), as of Mar 25, the value is 8.97. This value exceeds the healthy maximum of 2. It has increased from 4.38 (Mar 24) to 8.97, marking an increase of 4.59.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.46. This value exceeds the healthy maximum of 8. It has increased from 2.92 (Mar 24) to 11.46, marking an increase of 8.54.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.78. This value is below the healthy minimum of 20. It has decreased from 5.11 (Mar 24) to 4.78, marking a decrease of 0.33.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.28. This value is below the healthy minimum of 20. It has increased from 4.04 (Mar 24) to 4.28, marking an increase of 0.24.
• For Earning Retention Ratio (%), as of Mar 25, the value is 95.22. This value exceeds the healthy maximum of 70. It has increased from 94.89 (Mar 24) to 95.22, marking an increase of 0.33.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.72. This value exceeds the healthy maximum of 70. It has decreased from 95.96 (Mar 24) to 95.72, marking a decrease of 0.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 445.76. This value is within the healthy range. It has increased from 111.23 (Mar 24) to 445.76, marking an increase of 334.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 301.05. This value is within the healthy range. It has increased from 67.66 (Mar 24) to 301.05, marking an increase of 233.39.
• For Enterprise Value (Cr.), as of Mar 25, the value is 743.07. It has increased from 557.83 (Mar 24) to 743.07, marking an increase of 185.24.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.05. This value exceeds the healthy maximum of 3. It has decreased from 3.76 (Mar 24) to 3.05, marking a decrease of 0.71.
• For EV / EBITDA (X), as of Mar 25, the value is 7.94. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 7.94, marking a decrease of 3.46.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.23. This value exceeds the healthy maximum of 3. It has decreased from 3.89 (Mar 24) to 3.23, marking a decrease of 0.66.
• For Retention Ratios (%), as of Mar 25, the value is 95.21. This value exceeds the healthy maximum of 70. It has increased from 94.88 (Mar 24) to 95.21, marking an increase of 0.33.
• For Price / BV (X), as of Mar 25, the value is 4.18. This value exceeds the healthy maximum of 3. It has decreased from 4.55 (Mar 24) to 4.18, marking a decrease of 0.37.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.23. This value exceeds the healthy maximum of 3. It has decreased from 3.89 (Mar 24) to 3.23, marking a decrease of 0.66.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness